KO 대한민국

Akan Oton

Head of Pharmaceuticals, Private Equity/Real Assets

Akan Oton

Akan Oton is a member of Barings’ Private Equity / Real Assets team and leads the team’s investment strategy in pharmaceuticals. Akan has worked in the industry since 2002. Prior to joining the firm in 2017, Akan worked at Sandoz (a division of Novartis) where, among other duties, he was an Executive Director with responsibility for product acquisition, licensing and leading M&A initiatives in generics and specialty brand segments. Prior to Sandoz, he worked at Catalent Pharma Solutions, where he was responsible for product partnering and technology licensing for the company’s venture group. Akan previously held marketing leadership roles at both Cardinal Health and Johnson & Johnson. He holds a B.S. in Mechanical Engineering from Columbia University, an M.S. in Mechanical Engineering from Massachusetts Institute of Technology, where he was a National Science Foundation Graduate Fellow, and an M.B.A. from The Wharton School at the University of Pennsylvania. Akan currently serves on the boards of Kanwa Holdings LP and Validus Pharmaceuticals LLC.


베어링자산운용은 당사 웹사이트 사용자들에게 최적화된 웹 경험을 제공하고자 쿠키를 사용합니다.
베어링 웹사이트를 이용함으로써, 당사의 쿠키정책법적 & 개인정보고지사항에 동의하는 것으로 간주합니다.